Centene Completes Acquisition of PANTHERx Rare Pharmacy (PANTHERx)

ST. LOUIS, Dec. 30, 2020 /PRNewswire/ — Centene Corporation (NYSE: CNC) today announced that it has completed its acquisition of PANTHERx, one of the largest and fastest-growing specialty pharmacies in the United States specializing in orphan drugs and treating rare diseases. “We are…

About the Author

has written 20650 stories on this site.

Copyright © 2010-2019 strategicbusinessnews.com